[1] 侯晓玮,庄兴俊,宋谦,等.CT引导经皮肺穿刺活检检测晚期非小细胞肺癌表皮生长因子受体基因突变[J].介入放射学杂志,2013,22(2):125-128.
[2] 何光耀,谢貌,唐安洲,等.苦参碱对人鼻咽癌CNE2细胞裸鼠移植瘤生长及凋亡相关基因表达的影响[J].郑州大学学报(医学版),2014,49(2):169-172.
[3] 周娟,倪松石,贲素琴.苦参碱对人肺腺癌A549细胞增殖及HIF-10α,VEGF表达的影响[J].山东医药,2012,52(3):25-27.
[4] 蔡俊霞,谭洁,王彬,等.DC—CIK治疗43例晚期非小细胞肺癌的近期疗效观察[J].现代肿瘤医学,2014,22(1):67-70.
[5] Hsieh M J,Tsai T L,Hsieh Y S,et al.Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines[J].Archives of toxicology,2013,87(11):1927-1937.
[6] 敖曼,连相尧,刘承一,等.参芪扶正注射液对肺癌化疗患者造血功能和免疫功能的影响[J].山东医药,2012,52(3):60-61.
[7] 丁春杰,杨磊.参芪扶正注射液对晚期非小细胞肺癌化疗患者免疫功能的影响[J].西部中医药,2012,25(1):7-9.
[8] 殷舞,钟晓刚,黄顺荣,等.PI3K/Akt/mTOR信号通路在大肠腺瘤恶性转化中的表达及意义[J].广东医学,2013,34(2):238-240.
[9] 隋华,付晓伶,潘树芳,等.PI3K/Akt/NF-κB通路调控ABCB1/P-gp介导的人结肠癌细胞多药耐药的研究[J].中国癌症杂志,2014,24(2):106-111.
[10] Gadgeel S M,Wozniak A.Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer[J].Clinical lung cancer,2013,14(4):322-332.
[11] 成撒诺,徐亚丽,戴晓波,等.Krüppel样转录因子8在肝细胞癌中经PI3K/Akt通路调控VEGFA的表达[J].肿瘤,2016,34(12):1075.
[12] 鲍娇琳,陆金健,陈修平,等.苦参碱与氧化苦参碱抗肿瘤作用及其机制的研究进展[J].中药新药与临床药理,2012,23(3):369-373.
[13] 殷飞,赵军艳,姚树坤.苦参碱对SMMC-7721细胞MAPK,JAK—STAT信号通路的影响[J].肿瘤防治研究,2008,35(2):84-87.
[14] 陈晓峡,向小庆,叶红.苦参碱及氧化苦参碱抗肿瘤作用的研究进展[J].中国实验方剂学杂志,2013,19(11):361-364.
[15] Papadimitrakopoulou V.Development of PI3K/AKT/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancer[J].Journal of Thoracic Oncology,2012,7(8):1315-1326.
[1]姜恩顺,代金刚,林洪生,等.林洪生教授辨证论治肺癌的经验发微[J].环球中医药,2013,6(03):205.
[2]杨彩霞 赵远红.以便秘为首发症状的老年肺癌1例漏诊分析[J].环球中医药,2014,7(10):809.
[3]霍志刚,马小莉,李建设,等.肺癌恶性胸腔积液中医证型分布的相关性研究[J].环球中医药,2015,8(11):1346.[doi:10.3969/j.issn.1674-1749.2015.11.018]
HUO Zhi gang,MA Xiao li,LI Jian she,et al.Study on the correlation of distribution characteristics of TCM syndrome types of malignant pleural effusions of Patients with Lung cancer[J].,2015,8(08):1346.[doi:10.3969/j.issn.1674-1749.2015.11.018]
[4]王帅,钱彦方,杨雪春.中医体质学说在肺癌临床论治中的研究进展[J].环球中医药,2016,9(12):1560.[doi:10.3969/j.issn.1674-1749.2016.12.041]
WANG Shuai,QIAN Yan-fang,YANG Xue-chun..Research progress of TCM constitution theory in the treatment of lung cancer[J].,2016,9(08):1560.[doi:10.3969/j.issn.1674-1749.2016.12.041]